Attitudes towards the sharing of genetic information with at-risk relatives: results of a quantitative survey by Heaton, T.J. & Chico, V.
	



	
			

	
	

	
				


 	
!∀#
!∃%&∋()				
	∗
∗	
+	
	
	,		
−			. +/	!∋0%∋(∋&,∋&
		1

∗∋&∋&&2&&30,&∋,∋4∋,5
			
	
	6	

				

1 3
Hum Genet (2016) 135:109–120
DOI 10.1007/s00439-015-1612-z
ORIGINAL INVESTIGATION
Attitudes towards the sharing of genetic information with at-risk 
relatives: results of a quantitative survey
Timothy J. Heaton1 · Victoria Chico2 
Received: 10 July 2015 / Accepted: 6 November 2015 / Published online: 26 November 2015 
© The Author(s) 2015. This article is published with open access at Springerlink.com
characteristics than statistical risk. Respondents generally 
expressed strong attitudes demonstrating that this was not 
an issue which people felt ambivalent about. We provide 
estimates of the British population in favour/against disclo-
sure for various disease scenarios.
Introduction
The past decade of progress in genetics has provided trans-
formative opportunities for human health through improved 
diagnosis, prevention and treatment of disease (Green et al. 
2011). Knowledge of an individual’s genome allows access 
to personal health risks and the potential for preventative 
and tailored treatment or, in the case of a disease that can-
not be avoided, a chance to prepare for its development 
(Bradbury et al. 2015; Bunnik et al. 2015; Wilde et al. 
2011; Foster et al. 2009; Sanderson et al. 2004). However, 
genetic knowledge presents significant societal challenges 
because the information discovered is not solely personal. 
Genetic tests provide information that is not relevant just 
to the individual tested (proband) but also that person’s 
family. This raises the issue of whether such information 
should be shared with relatives and what should be done if 
the proband is unwilling to share.
Clinical genetics services have faced the issue of 
whether to share genetic information with at-risk relatives 
for decades. However, the rise of next generation sequenc-
ing in clinical care, in the form of targeted panel testing and 
whole genome sequencing1 and the mainstreaming of 
genetic medicine have greatly increased the prevalence of 
such familial disclosure issues. Furthermore, as described 
1 (e.g. http://www.genomicsengland.co.uk/).
Abstract To investigate public attitudes towards receiv-
ing genetic information arising from a test on a relative, 
955 University of Sheffield students and staff were sur-
veyed using disease vignettes. Strength of attitude was 
measured on whether, in the event of relevant informa-
tion being discovered, they, as an at-risk relative, would 
want to be informed, whether the at-risk relative’s interest 
should override proband confidentiality, and, if they had 
been the proband, willingness to give up confidentiality 
to inform such relatives. Results indicated considerably 
more complexity to the decision-making than simple sta-
tistical risk. Desire for information only slightly increased 
with risk of disease manifestation [log odds 0.05 (0.04, 
0.06) per percentage point increase in manifestation risk]. 
Condition preventability was the primary factor increas-
ing desire [modifiable baseline, non-preventable log odds 
−1.74 (−2.04, −1.44); preventable 0.64 (0.34, 0.95)]. 
Disease seriousness also increased desire [serious base-
line, non-serious log odds −0.89 (−1.19, −0.59); fatal 
0.55 (0.25, 0.86)]. Individuals with lower education levels 
exhibited much greater desire to be informed [GCSE log 
odds 1.67 (0.64, 2.66)]. Age did not affect desire. Our find-
ings suggest that attitudes were influenced more by disease 
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by Lucassen and Parker (2010), the technological develop-
ments in the possibilities for treatment have made finding 
the correct balance between the competing public interests 
of patient confidentiality and the avoidance of harm to rela-
tives both more difficult and pertinent.
Professional guidance on when it may be permissible to 
share genetic information with at-risk relatives does exist. 
In the UK, the Joint Committee on Medical Genetics (RCP, 
RCPath, BSHG 2011) views as good practice “appropri-
ate use of [a proband’s] genetic information to benefit the 
clinical management of family members” and recommends 
attempting to obtain consent for such communication from 
a proband prior to any genetic investigation. However, 
in situations where the scope of such consent is unclear 
or has been refused, the Joint Committee recognises that 
there may be circumstances where disclosure to prevent 
serious harm in a relative is still justified. Similar guid-
ance is found in other genomic (Human Genetics Com-
mission Inside information 2002) and non-genomic clini-
cal contexts (General Medical Council Consent: patients 
and London: GMC 2008). In the US, the American Society 
of Human Genetics (American Society of Human Genet-
ics 1998) and the President’s Commission for the Study 
of Ethical Issues in Biomedical and Behavioural Research 
(President’s Commission for the Study of Ethical Problems 
in Medicine and Biomedical Behavioural Research 1983) 
have also provided professional guidance. They too support 
gaining proband consent before disclosing information to 
relatives but also outline circumstances in which they con-
sider it acceptable to breach patient confidentiality if such 
consent in refused—if serious, immediate, and foreseeable 
harm to relatives was likely to occur that could otherwise 
be prevented.
Despite this guidance, the issue of when disclosure to 
family members might be acceptable (or even desirable) 
is still highly contentious and subject to legal challenge. In 
the US, relatives’ desire to receive genetic information has 
led to a legal duty to warn relatives of familial health risks. 
However, it is not clear whether this duty can be discharged 
by informing the proband (Pate v Threlkel) or whether the 
duty prevails if the proband prefers not to disclose (Safer v 
Pack). A similar duty does not exist in the UK. Thus, UK 
physicians have to make difficult assessments of patients’ 
and relatives’ interests in knowing, not knowing and in hav-
ing their confidence respected. UK hospitals have reached 
out of court settlements for failing to warn family members 
of known genetic risks discovered from tests on a relative 
(British Society for Genetic Medicine Annual Conference, 
Arena and convention centre Liverpool. private communi-
cation, September 2013). However, the English courts have 
recently denied that doctors owe an at-risk family member 
a duty to be informed in the face of the proband’s refusal 
to consent to the release of such information (ABC v St 
George’s Healthcare NHS Trust & others). However, the 
decision to grant the aggrieved relative leave to appeal in 
this case means that the legal position on disclosure to at-
risk relatives remains unclear.
As the Joint Committee on Medical Genetics (RCP, 
RCPath, BSHG 2011) states, the fundamental challenge 
for health professionals in making decisions on disclosure 
to at-risk relatives is in the balancing of three competing 
tensions: confidentiality to patients; the potential benefit 
of sharing information with family members; and respect-
ing the possibility such family members may wish not to 
receive such information. As a consequence it is vital that 
any guidance given to health professionals is seen to reflect 
public opinion.
There is a growing body of literature considering dis-
closure of unexpected genetic findings to individuals. 
However, much of this research concentrates on the return 
of results to probands rather than the question of inter-
est here—the disclosure of information to at-risk rela-
tives. This work on the return of genetic information to 
probands primarily focuses on the views of patients regard-
ing the receipt of information themselves from their own 
test (e.g. Middleton et al. 2015; Clift et al. 2015; Facio 
et al. 2013; McGowan et al. 2013). While there are some 
overlaps between this issue and the disclosure to at-risk 
relatives there are also significant differences. Furthermore, 
much of this literature on return of results to probands con-
siders the research rather than clinical context, where dif-
ferent concerns arise (Middleton et al. 2015). It can, there-
fore, only provide limited insight into questions relating to 
the disclosure to at-risk relatives.
Whilst there is a literature considering disclosure of 
genetic information to at-risk relatives, much is based upon 
theoretical and ethical positions (see, for example, Parker 
2012; Chico 2012; Knoppers 2002; Knoppers et al. 1998). 
Gaff and Bylund (2010) also provide a practical frame-
work, based upon family communication theory, on the 
approach to the communication and informing of family 
members about genetic information. Empirical work on 
disclosure to family members can be split into studies on 
the attitudes/experiences of three distinct groups: genetic 
health professionals, patients, and would-be relatives. A 
systematic review of this work can be found in Dheensa 
et al. (2015). Until now, the predominant focus has been 
on the attitudes of genetic health professionals (Klemenc-
Ketiš and Peterlin 2014; Yu et al. 2014; Strong et al. 2014; 
Ramoni et al. 2013; Lemke et al. 2013; Stol et al. 2010; 
Erde et al. 2006; Clarke et al. 2005; Falk et al. 2003; Dugan 
et al. 2003). There are a small number of primary stud-
ies considering patients’ attitudes to disclosure of their test 
results to relatives (Kohut et al. 2007; Pentz et al. 2005; 
Wilcke et al. 1999). However, there are very few empiri-
cal studies which investigate unsuspecting relatives, or 
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potential unsuspecting relatives’ views regarding what 
information they do, or do not, want to receive (Daack-
Hirsch et al. 2013; Wolff et al. 2007; Suthers et al. 2006). 
Amongst these three distinct study groups, health profes-
sionals generally express a feeling of responsibility towards 
at-risk relatives but identify difficulties in acting upon this 
responsibility. The views of the public appear more varied 
although the limited studies on would-be relatives indicate 
that the majority of people do want to be informed about 
the existence of a hereditary disease within their family and 
consider breaches of proband confidentiality acceptable in 
certain circumstances.
This paper begins to address the need to gather and 
understand public opinion and investigates whether the cur-
rent recommendations reflect public views. We investigate, 
via a survey of university staff and students, attitudes on 
disclosure of unsolicited genetic information to at-risk rela-
tives following the testing of another individual. We quan-
tify the specific factors influencing strength of attitude on 
what information at-risk relatives wish to know; whether 
an at-risk relatives’ interest should override any views of 
the proband; and willingness to forgo one’s own confiden-
tiality. We study the effect of both the characteristics of 
the disease such as seriousness, preventability and risk of 
it manifesting; and also the personal demographics of the 
respondent (e.g. age and sex). In an extension, we consider 
what the views of our university-based respondents sug-
gest about the wider population. Reweighting our sample to 
reflect the demographics of the British (i.e. English, Scot-
tish and Welsh) population, we provide preliminary esti-
mates on the proportion of the public who do, and do not, 
favour disclosure together with what information they do, 
and do not, want to know.
Materials and methods
Data collection and study design
Questions of interest
We analysed opinion on three specific questions relating 
to the disclosure of genetic information to at-risk relatives, 
see Fig. 1. For a particular genetic finding on a proband (1) 
would an at-risk relative wish, or not wish, to be contacted 
and informed about their resultant risk of a disease, (2) 
whether these at-risk relatives believed their interest should 
override the proband’s confidentiality, and (3) if the relative 
themselves had been the tested individual, how willing did 
they feel they would be to give up their own confidentiality 
so that at-risk relatives could be informed?
To investigate the factors influencing attitudes on these 
three questions, we created an online survey presenting a 
set of vignettes showing a range of possible disease sce-
narios. The disease characteristics chosen to vary between 
vignettes were informed by preliminary focus groups.
Preliminary focus groups
We ran two focus groups to determine the potential key 
factors affecting desire to receive genetic information 
which could then be varied in the vignettes and tested for 
their influence on attitudes. Focus group participants were 
recruited via a public engagement event at the University 
of Sheffield and a local newspaper. Sixteen females and 
8 males, with ages ranging from early 20s to late 70s and 
covering a mix of employed, unemployed and retirees from 
manual, skilled and professional occupations attended. 
Groups were audio-recorded before being transcribed and 
inputted to NVivo (Version9). Analysis identified and cate-
gorised topics and frequencies before establishing primary, 
secondary and lower level coding for the factors influenc-
ing the group’s views, priorities and preferences.
Vignette design and online survey
The seriousness of the condition, the absolute risks of dis-
ease manifestation for the at-risk relative both before and 
after the test on the proband was performed, and the possi-
bility of disease prevention were identified as the potential 
key influences to be tested by variation between vignettes. 
Details on the levels of each factor and overall design can 
be seen in Table 1. This provided us with a vignette bank 
of 54 differing disease scenarios. Each participant in the 
online survey was presented with four vignettes selected 
uniformly at random from this bank and asked for their 
attitudes on our three questions of interest. Visual repre-
sentations of the absolute numerical risks, as recommended 
by the Presidential Committee for the Study of Bioethical 
Issues (Presidential Commission for the Study of Bioethi-
cal Issues 2013), were used alongside written explanations 
to aid comprehension (see Fig. 1 for a sample vignette). 
The draft survey was piloted with three individuals 
recruited from the focus groups to determine whether the 
questions were understood as intended. Ethical approval 
was obtained from the University of Sheffield Research 
Ethics Committee.
Outcome measures
Responses to our three questions of interest were measured 
on a five-point Likert-type scale to rate strength of atti-
tude ranging from strong no/strongly disagree (response 
1) through no opinion (response 3) to strong yes/strongly 
agree (response 5). Personal demographics, also based on 
themes identified by the focus groups, were collected for 
112 Hum Genet (2016) 135:109–120
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Fig. 1  A sample vignette 
shown to respondents. Numeri-
cal risks were visually repre-
sented as well as given in the 
text. Examples were also given 
as to what was meant by the 
differing seriousness and modi-
fiability disease categories to 
increase comparability between 
respondents
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each respondent (five characteristics). It was made explic-
itly clear that respondents should base their decisions 
solely upon their personal desire for the information and to 
assume it would not also be disclosed to third parties, for 
example, insurance companies.
Participants
The survey was made available to the University of Shef-
field volunteers list2 for a period of three months from 
October to December 2013. During this time responses 
from 955 students and staff were obtained. This provided 
views on 3820 scenarios. See Table S1 in supplementary 
information for demographic details on respondents.
Analysis
Proportional odds logistic regression
To investigate the factors influencing attitudes, a propor-
tional odds logistic regression with random effects was fit-
ted to the responses using Bayesian MCMC. Further details 
can be found in Appendix A. Baseline views correspond to 
a 25–40-year-old female who has a university education, is 
not religious and does not have a partner. The baseline dis-
ease is serious and modifiable; pre- and post-test baseline 
risks are taken to be zero.
Extension to the wider population—reweighting 
demographics
While our study was performed on university-based 
respondents and, being an online survey, permitted self-
selection amongst respondents, we can still consider 
2 This list comprises current and retired staff of all grades and current 
students at the University of Sheffield unless they have chosen to opt 
out and remove themselves from it.
what it might tell us about the views of the wider popu-
lation. This can be achieved by reweighting, according 
to the demographic information, the responses of our 
survey to represent the population as a whole. NatCen 
Social Research British social attitudes survey 2nd Edi-
tion (2011) provides a breakdown of the proportion of 
individuals of each age, sex, education level, relation-
ship status and religious view. For each of these groups, 
our proportional odds logistic model can provide an esti-
mate of views. These can then be combined to provide 
an estimate of a representative sample of society. To pro-
vide such estimates, 2000 samples were drawn from our 
MCMC chains for each of our three questions of interest. 
We report the means and 95 % intervals for the predicted 
proportion of individuals in the British population hold-
ing each view.
Results
Consistent values were reflected across the three questions. 
A stronger desire to know information as a prospective at-
risk individual usually corresponds to a stronger belief that 
the relative’s right to know should override the proband’s 
interest in confidentiality (Kendall correlation 0.51, p 
value <2 × 10−16). It also corresponds to a greater happi-
ness to forgo one’s own confidentiality to inform at-risk 
relatives (0.36, p value <2 × 10−16).
Tables 2, 3 and 4 provide posterior estimates and 95 % 
credible intervals for the effect of the various disease and 
personal characteristics on our three questions of inter-
est. Positive values indicate individuals/diseases with the 
particular characteristic are more likely to give a higher 
(more positive) response; conversely negative values are 
more likely to lead to a lower (more negative) response. 
The estimates of random effect size quantify the amount of 
natural variation amongst the population.
We also present in Table 5, and Table S2 in supplemen-
tary information, our estimates (based on survey reweight-
ing) of the proportion of the British population in each 
response category together with 95 % intervals for each 
combination of disease seriousness and preventability. 
Since the absolute changes affected by pre- and post-test 
risk are small we only provide two illustrative levels of 
pre- and post-test risk. Table 5 (used for discussion below) 
presents the views for diseases where the pre-test risk for 
the concerned relative was believed to be 1 % and the post-
test risk 2 % and Table S2 presents the views for a pre-
test risk of 10 % and a post-test risk of 20 %. In all three 
questions asked, few individuals fall into the class of “no 
opinion”, indicating strong attitudes and little ambivalence 
regarding disclosure and receipt of information on genetic 
risks.
Table 1  Levels of factors chosen for quantitative survey
Disease Seriousness Disease 
Preventability
Comparative Level of Risk
Pre-test risk 
level
Post-test risk 
level
(%) (%)
Non-serious Non-preventable 1 2
5
Serious Modifiable 10
(but not usually directly fatal) 10 12
Fatal Preventable 20
50
We defined three hypothetical levels for the disease seriousness and 
three for preventability. We also selected two levels of pre-test risk for 
the at-risk relative, each with a further three levels of post-test risk. 
To create a vignette, one level was chosen from each factor at random
114 Hum Genet (2016) 135:109–120
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What information do at-risk relatives want to know?
Factors affecting attitude
As shown in Table 2, the most critical factor affecting 
desire to be informed is whether action can be taken to 
avoid the disease. As indicated in the increase in γ̂k from 
non-preventable through modifiable to preventable, such 
desire increases with preventability, e.g. compared with 
modifiable baseline, non-preventable log odds of −1.74 
(−2.04 to −1.44) and preventable log odds 0.64 (0.34–
0.95) for a serious but non-fatal condition. Individuals 
are also more likely to want information as the condition 
becomes more serious, e.g. considering a modifiable con-
dition we have, compared to the serious disease baseline, 
a non-serious disease log odds of −0.89 (95 % CI −1.19 
to −0.59) and a fatal disease log odds of 0.55 (95 % CI 
0.25–0.86). Altering either of these characteristics has 
large absolute effects on strength of opinion. Desire also 
increases as your believed risk of developing the disease, 
in light of the test, increases (log odds 0.05, with 95 % CI 
of 0.04–0.06, for each 1 % increase in posterior risk). Indi-
viduals are less concerned to know about diseases which 
are already more common in the population (pre-risk log 
odds −0.07 with 95 % CI of −0.09 to −0.05). However, 
while these two risk factors are statistically significant their 
absolute effect on attitude is small compared with the other 
disease characteristics. This suggests that either individuals 
struggle to fully understand quantitative risk in the context 
of genetic information, or that decisions are primarily made 
based upon attitudes towards the possession of personalised 
(and familial) information relating to oneself per se rather 
than actual informativeness.
Age does not have a significant influence (95 % CIs 
for all age groups overlapping 0). Neither does relation-
ship status (95 % CI of −0.38 to 0.26) nor religious belief 
(95 % CI of −0.45 to 0.16). There is strong evidence that 
those individuals with GCSE or equivalent as their highest 
level of qualification are considerably more likely to desire 
information about themselves (βˆ = 1.67, 95 % CI of 0.64–
2.66) while little difference is seen between those educated 
to A-level or beyond. There is also some evidence that men 
have a stronger desire for information than women (0.26, 
95 % CI −0.01 to 0.54).
Proportions in the general population
For conditions which are either modifiable or prevent-
able, our survey suggests that (were the views of our 
university respondents to be reflected across wider soci-
ety) a significant majority of the public would want to be 
informed. For a preventable and fatal disease, our sur-
vey predicts 91 % (CI 88–94 %) “would like to be con-
tacted” and 63 % (CI 54–70 %) would feel “very strongly 
that [they] would like to be contacted”. This desire to 
be informed also extends to non-serious conditions. 
Few individuals would appear to feel, for a modifiable 
or preventable condition, “that [they] would NOT like 
to be contacted”; modifiable and non-serious 19 %, CI 
15–25 %; preventable and fatal 5 %, CI 3–7 % with very 
few feeling “very strongly that [they] would NOT like 
to be contacted”. This perhaps suggests that in the case 
Table 2  Factors affecting an individual’s desire to know their genetic 
information
Category Posterior Quantiles
Mean 2.5 % 97.5 %
Age
16–25 0.08 −0.23 0.41
25–40 – – –
40–60 −0.18 −0.62 0.25
Over 60 −0.55 −1.46 0.39
Max. education level
GCSE 1.67 0.64 2.66
A-level 0.09 −0.31 0.50
University – – –
Other demographic factors
In relationship −0.07 −0.38 0.26
Religious −0.14 −0.45 0.16
Sex (male) 0.26 −0.01 0.54
Type of disease
Non-serious
Non-preventable −2.44 −2.73 −2.14
Modifiable −0.89 −1.19 −0.59
Preventable −0.61 −0.90 −0.31
Serious (but not fatal)
Non-preventable −1.74 −2.04 −1.44
Modifiable – – –
Preventable 0.64 0.34 0.95
Fatal
Non-preventable −1.73 −2.03 −1.43
Modifiable 0.55 0.25 0.86
Preventable 1.23 0.91 1.54
Risk factors
Pre-risk −0.07 −0.09 −0.05
Post-risk 0.05 0.04 0.06
Random effect (Population variation)
σ 1.74 1.60 1.89
Category boundaries (desire to be contacted)
V. strong no/no,  a1 −4.71 −5.11 −4.29
No/no opinion, a2 −2.55 −2.90 −2.17
No opinion/yes,  a3 −1.71 −2.06 −1.35
Yes/V. strong yes,  a4 1.00 0.66 1.35
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of a modifiable or preventable disease, we should not 
be too concerned about giving information that people 
might not want to know because very few people have 
such a desire. For non-preventable conditions, however, 
our survey suggests that approximately 25–40 % may not 
want to receive genetic information about themselves no 
matter what the level of seriousness—fatal 29 % (23–
36 %); serious 39 % (32–47 %); and non-serious 39 % 
(32–47 %).
Should an at-risk relative’s right to know override 
proband confidentiality?
Factors affecting attitude
Table 3 demonstrates that excepting those with a maximum 
education level of GCSE who are more likely to believe 
disclosure should take precedence (βˆ = 1.99, 95 % CI 
0.69–3.30), personal characteristics make no significant 
difference to views on the relative importance of maintain-
ing confidentiality. Potential for disease prevention again 
has the largest impact with support for overriding confi-
dentiality increasing with preventability, e.g. compared 
to modifiable baseline, non-preventable log odds −1.07 
(−1.38 to −0.77) and preventable 0.60 (0.30–0.91). Dis-
ease seriousness has an almost equally significant role with 
support for disclosure increasing with seriousness (non-
serious −0.86, −1.17 to −0.55; fatal 0.84, 0.53–1.15). Pre-
test risk (−0.05, 95 % CI −0.07 to −0.03) and post-test 
risk (0.04, 95 % CI 0.03–0.04) of disease development are 
shown to be statistically significant factors but again the 
absolute change in opinion they affect is small in compari-
son to changes in disease seriousness and preventability.
Proportional views in the general population
Where the condition is non-preventable, demographic 
reweighting of our survey responses suggests that the 
majority of the public do not believe their right to know 
should override the proband’s right to confidentiality (non-
serious 61 %, 52–70 %; fatal 44 %, 36–53 %). The pro-
portion who feel strongly that [their] right to know should 
NOT override the proband’s right to confidentiality is high 
(non-serious 29 %, 23–36 %; fatal 16 %, 12–22 %). How-
ever, where the disease is either serious or fatal, and some 
level of preventative action is possible, support for overrid-
ing proband confidentiality increases greatly. In the case of 
a fatal and preventable disease, our survey suggests only 
20 % (15–27 %) of the public believe their right to know 
should not override the proband’s confidentiality, compared 
with 72 % (65–79 %) who believe it should and 40 % (CI 
32–50 %) strongly believing so.
Are individuals willing to forgo their own 
confidentiality in genetic tests so that an at-risk relative 
could be informed?
Factors affecting attitude
Table 4 indicates increased willingness to forgo confiden-
tiality for diseases which are more preventable (compared 
to baseline, non-preventable −1.12, −1.51 to −0.74; pre-
ventable 0.54, 0.14–0.94) and serious (non-serious log 
Table 3  Factors affecting an individual’s belief that their right to 
know, as an at-risk relative, should override the confidentiality of the 
proband
Category Posterior Quantiles
Mean 2.5 % 97.5 %
Age
16–25 0.18 −0.26 0.61
25–40 – – –
40–60 0.09 −0.48 0.70
Over 60 −0.40 −1.67 0.83
Max. education level
GCSE 1.99 0.69 3.30
A-level −0.07 −0.64 0.49
University – – –
Other demographic factors
In relationship −0.20 −0.65 0.24
Religious 0.02 −0.41 0.43
Sex (male) −0.03 −0.43 0.38
Type of disease
Non-serious
Non-preventable −2.23 −2.54 −1.92
Modifiable −0.86 −1.17 −0.55
Preventable −0.44 −0.75 −0.14
Serious (but not fatal)
Non-preventable −1.07 −1.38 −0.77
Modifiable – – –
Preventable 0.60 0.30 0.91
Fatal
Non-preventable −0.81 −1.13 −0.49
Modifiable 0.84 0.53 1.15
Preventable 1.54 1.22 1.86
Risk factors
Pre-risk −0.05 −0.07 −0.03
Post-risk 0.04 0.03 0.04
Random effect (Population variation)
σ 2.68 2.50 2.87
Category boundaries (should right to know override confidentiality?)
Strong no/no, a1 −3.37 −3.86 −2.88
No/no opinion, a2 −0.52 −0.99 −0.06
No opinion/yes, a3 0.30 −0.17 0.75
Yes/strong yes, a4 3.13 2.63 3.60
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odds −0.79, 95 % CI −1.18 to −0.40; fatal 0.33, −0.06 to 
0.73). Of these two factors, preventability is again predomi-
nant. Pre-test (−0.07, −0.10 to −0.05) and post-test (0.05, 
0.04–0.06) disease risks also have a statistically significant 
effect but small in absolute terms. There is some evidence 
that those in relationships are happier to forgo confidential-
ity (0.59, 0.01–1.19) while those who are religious are less 
willing (−0.73, −1.25 to −0.20). There is no evidence that 
age, sex or education level significantly affect willingness 
to forgo one’s own confidentiality.
The random effect standard deviation (3.12, 2.87–3.39) 
is large indicating this question has the largest spread of 
views amongst the population. Despite a general will-
ingness to share, some individuals are strongly against 
the idea of forgoing their own confidentiality whatever 
the information. 20 of our 955 participants indicated an 
unhappiness to forgo confidentiality in all vignettes pre-
sented. Interestingly, these particular 20 individuals were 
not consistent in their views across the alternate questions 
with a significant number responding that, were they the 
at-risk relative, they would want to be told. Some also felt 
that such disclosure was more important than proband 
confidentiality.
Proportional views in the general population
Irrespective of the nature of the information, people appear 
generally happy to forgo their own confidentiality in the 
context of genetic findings relevant to family members. 
In the case of a fatal and preventable disease, we estimate 
93 % (90–96 %) of the British public would be willing to 
forgo their confidentiality with 72 % (63–79 %) strongly 
so. For a non-serious and non-preventable disease these 
proportions drop to 77 % (70–84 %) and 43 % (33–54 %), 
respectively. A small proportion (1 % for a fatal and pre-
ventable disease) is indicated to be unwilling to forgo their 
confidentiality in any circumstance.
Discussion
What does this study tell us?
Our study of 955 university-based respondents shows 
that making decisions about disclosing and receiving 
genetic information in families is extremely complex and 
based on much more than statistical risk. We found that 
the most important factor affecting an at-risk relative’s 
desire to know genetic information is the preventability 
of the disease to which the information relates. Disease 
seriousness is also highly important. While informa-
tiveness of the test, as measured by the increase in the 
believed risk of disease development for the at-risk rela-
tive from pre- to post-test, is seen to have a statistically 
significant the absolute effect is small in comparison to 
the disease seriousness or preventability. This suggests 
that even when a test indicates in a small increase in the 
chance of developing a disease, at-risk relatives may still 
want to be informed if action is possible to modify this 
risk of onset. Such views may be due to decisions being 
based upon attitudes towards possession of any available 
Table 4  Factors affecting whether an individual would be happy to 
forgo their right to confidentiality in the event they were a proband 
in a genetic test from which information, pertaining to a disease was 
found that was of relevance to a relative
Category Posterior Quantiles
Mean 2.5 % 97.5 %
Age
16–25 0.27 −0.44 0.89
25–40 – – –
40–60 −0.06 −0.87 0.69
Over 60 0.86 −0.79 2.54
Max. education level
GCSE 1.57 −0.17 3.29
A-level 0.26 −0.46 0.95
University – – –
Other demographic factors
In relationship 0.59 0.01 1.19
Religious −0.73 −1.25 −0.20
Sex (male) −0.20 −0.67 0.27
Type of disease
Non-serious
Non-preventable −1.86 −2.24 −1.47
Modifiable −0.79 −1.18 −0.40
Preventable −0.39 −0.78 0.00
Serious (but not fatal)
Non-preventable −1.12 −1.51 −0.74
Modifiable – – –
Preventable 0.54 0.14 0.94
Fatal
Non-preventable −1.00 −1.39 −0.60
Modifiable 0.33 −0.06 0.73
Preventable 1.00 0.59 1.42
Risk factors
Pre-risk −0.07 −0.10 −0.05
Post-risk 0.05 0.04 0.06
Random effect (Population variation)
σ 3.12 2.87 3.39
Category boundaries (as the proband would you forgo confidentiality?)
V. unhappy/unhappy, a1 −7.28 −8.18 −6.42
Unhappy/no opinion, a2 −4.88 −5.70 −4.07
No opinion/happy, a3 −3.99 −4.79 −3.18
Happy/V. happy,  a4 −0.47 −1.24 0.31
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information about oneself per se, the familial nature of 
the information, or perhaps simply a difficulty in under-
standing quantitative genetic risk. Views were mainly 
unaffected by demographic factors although those with 
lower levels of education express significantly more 
desire to be informed than those with higher level qualifi-
cations (above GCSE). The values that affect an individu-
al’s desire for information have a largely consistent effect 
on whether an individual believes the right of the at-risk 
relative should override the proband’s confidentiality and 
also their happiness to forgo their own confidentiality in 
the event they themselves were tested.
The Joint Committee on Medical Genetics (RCP, 
RCPath, BSHG 2011) reports the “feelings of altru-
ism and solidarity towards family members” that patients 
experience and notes that the majority are happy for their 
information to be shared. This position is reflected in our 
empirical work. Where patients are not happy to share 
information, professional guidance (RCP, RCPath, BSHG 
2011; HCG 2002; American Society of Human Genet-
ics (1998); President’s Commission for the Study of Ethi-
cal Problems in Medicine and Biomedical Behavioural 
Research 1983) reflects a consensus that there are certain 
circumstances where breach of patient confidentiality to 
inform relatives can be justified. Where confidentiality 
would be breached, much of this guidance only considers 
disclosure permissible when there is a high probability that 
serious harm will occur to the at-risk relative which could 
otherwise be avoided. This position to permit disclosure 
only in exceptional circumstances is not fully reflected in 
the views of our respondents. Since attitudes do not appear 
to be made primarily on the basis of statistical risk, the like-
lihood of harm does not appear to be the overriding factor 
influencing attitudes regarding when a breach of proband 
confidentiality is justified.
Strengths, weaknesses and further study
We believe our study to be the first large-scale (955 
respondents) quantitative study into the factors affecting 
attitudes to the disclosure of genetic information to unsus-
pecting at-risk relatives that specifically surveys the views 
of potential relatives through a selection of the population. 
The highly visual vignettes and simplicity of the design 
allowed scenarios to be easily understood and meant the 
survey maintained enthusiasm of respondents. We believe 
this, together with the clear interest in this issue amongst 
the public, can be seen by the large number of responses 
obtained.
Our measurement of strength of attitude is important in 
weighing the competing interests of proband and relative to 
inform public attitudes to the disclosure of genetic informa-
tion. Use of multiple responses also enables assessment of T
a
b
le
 5
 
 E
st
im
at
ed
 v
ie
w
s 
o
f 
re
p
re
se
n
ta
ti
v
e 
sa
m
p
le
 o
f 
B
ri
ti
sh
 p
u
b
li
c 
fo
r 
d
if
fe
re
n
t 
d
is
ea
se
 c
at
eg
o
ri
es
 w
h
en
 p
re
-r
is
k
 i
s 
1
 %
 a
n
d
 p
o
st
-r
is
k
 i
s 
2
 %
E
st
im
at
es
 o
f 
th
o
se
 e
x
p
re
ss
in
g
 “
n
o
 o
p
in
io
n
” 
ca
n
 b
e 
fo
u
n
d
 b
y
 c
al
cu
la
ti
n
g
 1
0
0
 −
 (
p
ro
p
o
rt
io
n
 ≤
 n
o
) 
−
 (
p
ro
p
o
rt
io
n
 ≥
 y
es
)
N
o
n
-p
re
v
en
ta
b
le
M
o
d
ifi
ab
le
P
re
v
en
ta
b
le
S
. 
n
o
≤
N
o
≥
Y
es
S
. 
y
es
S
. 
n
o
≤
N
o
≥
Y
es
S
. 
y
es
S
. 
n
o
≤
N
o
≥
Y
es
S
. 
y
es
W
o
u
ld
 y
o
u
 w
an
t 
to
 k
n
o
w
 t
h
is
 i
n
fo
rm
at
io
n
?
 N
o
n
-s
er
io
u
s
1
3
.5
 (
1
0
, 
1
8
)
3
8
.9
 (
3
2
, 
4
7
)
4
8
.4
 (
4
0
, 
5
7
)
1
4
.4
 (
9
, 
2
1
)
4
.7
 (
3
, 
7
)
1
9
.2
 (
1
5
, 
2
5
)
7
0
.9
 (
6
3
, 
7
7
)
3
1
.5
 (
2
3
, 
4
0
)
3
.8
 (
3
, 
6
)
1
6
.4
 (
1
2
, 
2
2
)
7
4
.5
 (
6
8
, 
8
0
)
3
5
.4
 (
2
7
, 
4
4
)
 S
er
io
u
s
8
.6
 (
6
, 
1
2
)
2
9
.2
 (
2
3
, 
3
6
)
5
9
 (
5
1
, 
6
6
)
2
1
.1
 (
1
4
, 
2
9
)
2
.3
 (
2
, 
4
)
1
1
.4
 (
8
, 
1
6
)
8
1
.4
 (
7
6
, 
8
6
)
4
4
.4
 (
3
5
, 
5
3
)
1
.3
 (
1
, 
2
)
7
.4
 (
5
, 
1
0
)
8
7
.1
 (
8
3
, 
9
1
)
5
4
.1
 (
4
5
, 
6
2
)
 F
at
al
8
.6
 (
6
, 
1
2
)
2
9
.1
 (
2
3
, 
3
6
)
5
9
.1
 (
5
1
, 
6
7
)
2
1
.2
 (
1
5
, 
2
9
)
1
.5
 (
1
, 
2
)
7
.9
 (
6
, 
1
1
)
8
6
.4
 (
8
2
, 
9
0
)
5
2
.7
 (
4
4
, 
6
1
)
0
.8
 (
0
, 
1
)
4
.9
 (
3
, 
7
)
9
1
.1
 (
8
8
, 
9
4
)
6
2
.8
 (
5
4
, 
7
0
)
S
h
o
u
ld
 s
h
ar
in
g
 o
v
er
ri
d
e 
co
n
fi
d
en
ti
al
it
y
 o
f 
te
st
ee
?
 N
o
n
-s
er
io
u
s
2
8
.7
 (
2
3
, 
3
6
)
6
0
.8
 (
5
2
, 
7
0
)
3
0
.4
 (
2
2
, 
3
9
)
9
.2
 (
5
, 
1
5
)
1
6
.8
 (
1
2
, 
2
2
)
4
5
 (
3
7
, 
5
4
)
4
5
.5
 (
3
6
, 
5
4
)
1
7
.5
 (
1
1
, 
2
5
)
1
3
.9
 (
1
0
, 
1
9
)
4
0
.1
 (
3
3
, 
4
9
)
5
0
.4
 (
4
2
, 
5
9
)
2
0
.8
 (
1
4
, 
2
9
)
 S
er
io
u
s
1
8
.4
 (
1
3
, 
2
4
)
4
7
.4
 (
3
9
, 
5
6
)
4
3
.1
 (
3
4
, 
5
2
)
1
6
 (
1
0
, 
2
3
)
1
1
.2
 (
8
, 
1
5
)
3
5
.3
 (
2
8
, 
4
4
)
5
5
.5
 (
4
6
, 
6
4
)
2
4
.6
 (
1
7
, 
3
3
)
8
.2
 (
6
, 
1
2
)
2
8
.9
 (
2
3
, 
3
6
)
6
2
.4
 (
5
4
, 
7
0
)
3
0
.5
 (
2
2
, 
3
9
)
 F
at
al
1
6
.4
 (
1
2
, 
2
2
)
4
4
.3
 (
3
6
, 
5
3
)
4
6
.1
 (
3
7
, 
5
5
)
1
7
.9
 (
1
2
, 
2
5
)
7
.3
 (
5
, 
1
0
)
2
6
.6
 (
2
1
, 
3
4
)
6
4
.9
 (
5
7
, 
7
2
)
3
2
.9
 (
2
5
, 
4
2
)
4
.8
 (
3
, 
7
)
2
0
.3
 (
1
5
, 
2
7
)
7
2
.2
 (
6
5
, 
7
9
)
4
0
.6
 (
3
2
, 
5
0
)
W
o
u
ld
 y
o
u
 b
e 
w
il
li
n
g
 t
o
 f
o
rg
o
 y
o
u
r 
co
n
fi
d
en
ti
al
it
y
 i
f 
y
o
u
 w
er
e 
te
st
ed
?
 N
o
n
-s
er
io
u
s
5
.2
 (
3
, 
8
)
1
6
.1
 (
1
1
, 
2
2
)
7
7
.5
 (
7
0
, 
8
4
)
4
3
.3
 (
3
3
, 
5
4
)
2
.9
 (
2
, 
5
)
1
0
.2
 (
7
, 
1
5
)
8
5
 (
7
9
, 
9
0
)
5
4
.5
 (
4
4
, 
6
4
)
2
.3
 (
1
, 
4
)
8
.4
 (
5
, 
1
3
)
8
7
.3
 (
8
2
, 
9
1
)
5
8
.6
 (
4
8
, 
6
8
)
 S
er
io
u
s
3
.5
 (
2
, 
6
)
1
1
.8
 (
8
, 
1
7
)
8
2
.9
 (
7
6
, 
8
8
)
5
1
 (
4
0
, 
6
1
)
1
.8
 (
1
, 
3
)
7
 (
5
, 
1
0
)
8
9
.3
 (
8
5
, 
9
3
)
6
2
.5
 (
5
3
, 
7
1
)
1
.3
 (
1
, 
2
)
5
.3
 (
3
, 
8
)
9
1
.7
 (
8
8
, 
9
5
)
6
7
.7
 (
5
8
, 
7
6
)
 F
at
al
3
.2
 (
2
, 
5
)
1
1
.2
 (
8
, 
1
6
)
8
3
.7
 (
7
7
, 
8
9
)
5
2
.3
 (
4
2
, 
6
2
)
1
.4
 (
1
, 
2
)
5
.9
 (
4
, 
9
)
9
0
.9
 (
8
7
, 
9
4
)
6
5
.9
 (
5
6
, 
7
4
)
0
.9
 (
0
, 
2
)
4
.1
 (
2
, 
6
)
9
3
.4
 (
9
0
, 
9
6
)
7
2
 (
6
3
, 
7
9
)
118 Hum Genet (2016) 135:109–120
1 3
the variation in opinion amongst the population. Quantify-
ing the impact of the absolute risks of disease manifesta-
tion may also help inform how far disclosure should extend 
within a family. Finally, via a sample reweighting, we are 
able to consider how our survey responses may generalise 
to the wider population providing preliminary estimates of 
the views of the British public.
Our study has limitations. Respondents were drawn from 
university staff and students who may have different views 
from those outside a university environment. In addition there 
is potential for self-selection bias within our sample. The 
survey was freely available online possibly leading to more 
responses from individuals with polarised views. Our exten-
sion estimating the proportion of the British population hold-
ing each view should, therefore, be treated as preliminary. Fur-
ther work is needed to recruit a truly representative sample.
Our survey is also only able to ask people about their atti-
tudes in hypothetical circumstances. How accurately hypo-
thetical views match behaviour in the context of a real situa-
tion is a potential criticism of our work. While much research 
has demonstrated a significant and substantial attitude–behav-
iour link (Glasman and Albarracin 2006, Kraus 1995) there 
are several cases where the uptake of genetic testing in prac-
tice has been considerably lower than self-reported interest 
would have suggested (e.g. Binedell and Soldan, 1997). It is 
not evident that this will affect the relative importance of the 
various factors in decision-making but it is possible that the 
real desire for genetic information may be below that reported 
in our study. This raises an important further issue since dis-
covering whether or not a potential at-risk relative wants 
to know a risk that is, as yet, unknown to them will always 
require a hypothetical approach. If one wishes to respect such 
a relative’s autonomy it is important to make sure that these 
self-reported hypothetical attitudes do agree with desired 
behaviour in reality. Glasman and Albarracin (2006) show 
that attitudes and behaviour are most closely aligned when 
views are held strongly, are stable over time and are based 
upon direct experience. While several of our scenarios dem-
onstrate that individuals do have strong views, much of the 
public is likely to have limited direct experience of genetic 
medicine. It is, therefore, crucial that individuals are fully 
educated before they make such decisions.
Additionally, we only presented disease categories (e.g. 
serious, modifiable, …). Views on the nature of these cate-
gories may vary amongst respondents and health profes-
sionals (Wertz and Knoppers 2002). A potential extension 
would be to study opinion for a range of specific disease 
states; for example, those recommended for screening by 
the American College of Medical Genetics and Genomics 
(Green et al. 2013) and Genomics England.3 Individuals 
3 http://www.genomicsengland.co.uk/library-and-resources/.
may, however, have limited/varying knowledge about such 
named conditions.
Our survey did not collect information on the profes-
sional background of the respondents. It would be of inter-
est to investigate whether, in the presented vignettes, the 
attitudes of healthcare professionals differed from those of 
the general public. Middleton et al. (2015) have recently 
demonstrated that there is a disconnect between the views 
of those handling research findings and those participating 
in research with regard to the feedback of genetic informa-
tion. Work to investigate the reasons behind the observed 
differences in attitudes amongst those with lower education 
would be valuable.
Implications for research and practice
Studying the views of the public towards disclosing genetic 
information to family members adds a valuable perspective 
to the existing empirical literature on professional views 
(Dheensa et al. 2015; Klemenc-Ketiš and Peterlin 2014; 
Lemke et al. 2013; Stol et al. 2010; Falk et al. 2003; Dugan 
et al. 2003; Clarke et al. 2005, Yu et al. 2014; Strong et al. 
2014; Ramoni et al. 2013; Erde et al. 2006). Our work dem-
onstrates people are not ambivalent about sharing genetic 
information within families. Instead, people have strong 
attitudes. This work further shows that attitudes to receiv-
ing and sharing genetic information in families might not 
rest predominantly on the particular characteristics of the 
information itself, but may instead be based on the individ-
ual’s attitude more generally to having information about 
themselves which exists and is known by others. The com-
plex and nuanced picture of attitudes to receiving unsolic-
ited genetic information demonstrated here complicate any 
effort to produce a single set of guidelines to inform when 
disclosure to at-risk family members should occur.
The ability to modify the risk of manifestation does, 
however, appear to be a key criterion perhaps with indi-
viduals coping more easily with adverse information if they 
can act practically upon it. For diseases which are modi-
fiable in some way our survey suggests a strong desire to 
be informed. In such circumstances, clinicians may wish 
to favour disclosure where this does not breach confidence 
because causing grievance based on a desire not to know is 
unlikely given the strong attitudes towards desiring action-
able information shown in this survey.
Medical actionability is not the only important factor. 
Desire for information also increases with disease serious-
ness and is significant even when the condition is not pre-
ventable suggesting individuals value being able to plan 
lifestyle and welfare issues in the light of knowledge they 
are at an increased risk of suffering from a serious condi-
tion (Foster et al. 2009; Bunnik et al. 2015; Bradbury et al. 
2015). Desire to know in such circumstances is, however, 
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balanced by a stronger desire not to know amongst some 
individuals. Here, therefore, there may be a risk of griev-
ance if people are informed when they feel they would have 
preferred not to know.
Our work also suggests people are highly willing to 
share personal information with members of their family. 
While the sharing of health data outside of the NHS is cur-
rently highly contentious, as demonstrated by ABC v St 
George’s Healthcare NHS Trust and others and Care.data,4 
it might be that concerns about confidentiality of health 
information are not common place in familial relationships 
and patients are happy to adopt a familial model to the 
sharing of genetic information (d’Agincourt-Canning 
2006). Although there seems to be a small minority who 
would not be happy to share their information it might be 
that a cultural shift where sharing becomes the norm will 
influence behaviour (see Bicchieri and Chavez (2010); Bic-
chieri (2009) for the effect of social norms on behaviour). 
Over time, the minority who oppose sharing may then find 
their position difficult to maintain and justify within a cul-
ture of sharing.
Conclusion
Our results indicate disease preventability and serious-
ness are the key factors in determining people’s attitudes 
towards receiving and sharing genetic information. The 
actual increase in risk of disease manifestation plays a 
much lesser role. Most respondents reported a willingness 
to consent to sharing pertinent genetic information with 
relatives and many would want such information to be 
shared with them even if this was against their tested rela-
tive’s wishes. Current professional guidance recognises 
that breach of proband confidence might be appropriate in 
narrowly defined circumstances where relatives are likely 
to suffer serious and preventable harm. However, our work 
indicates that people consider breaches may be permissi-
ble in a wider, and less strict, range of circumstances.
Further work is needed on the longer term impact on 
individuals receiving personal and uncertain genomic infor-
mation. Is receipt of such information a net good, can indi-
viduals understand the information they receive, and can it 
beassimilated beneficially into their lives?
4 Care.data is an NHS England initiative to take data from GP 
records and upload them to the national Health and Social Care Infor-
mation Centre (HSCIC) databases. The initiative had to be postponed 
in February 2014 due to a public backlash over, among other things, 
public concerns that patient information would be made available 
outside of the NHS, potentially to private companies.
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